Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT00238277 · TERMINATED
Trial details
- NCT number
- NCT00238277
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-15
- Primary completion
- 2007-12-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.